← All stocks

Healthpeak Properties

DOC Net buying
CIK 0000765880 #231 in the set updated 17 Sep 2026
Bought (120 mo)
$2.83M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$4.79M
$0.00 on a plan · $3.70M straight out of an exercise
Sold at will
$1.09M
14 of 16 sales
Net
−$1.96M
+$1.73M against sales at will

By person

34 insiders · 37 transactions
5.0×

Scott M. Brinker holds 5.0 times base salary in stock. $4.18M of shares against $825.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Scott M. Brinker last reported holding, valued at $19.45, the price Common Stock was last bought or sold at on the open market here, on 12 May 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Klaritch Thomas
COO
$35.20K (1)
$3.78M (3) scheduled
−$3.74M
330,412
0.0479%
$6.43M
+77.3%
Brinker Scott M
President and CEO
$758.48K (6)
+$758.48K
214,688
0.0311%
$4.18M
Lewis Sara Grootwassink
Director
$588.82K (4)
+$588.82K
65,488
0.0095%
$1.27M
Griffin R Kent Jr
Director
$502.18K (1)
+$502.18K
90,195
0.0131%
$1.75M
+2,810%
GARVEY CHRISTINE
Director
$496.50K (11)
−$496.50K
30,820
0.0045%
$599.46K
+95.6%
Young Kendall K
Executive Vice President
$306.74K (1)
+$306.74K
68,659
0.0100%
$1.34M
+70.8%
Anderson Scott A
EVP and CAO
$299.41K (1)
−$299.41K
27,345
0.0040%
$531.87K
−8.2%
Bohn Scott R
CDO and Head of Lab
$213.74K (1)
−$213.74K
7,636
0.0011%
$148.52K
−71.4%
Sandstrom Katherine M
Director
$199.23K (1)
+$199.23K
76,669
0.0111%
$1.49M
Thompson Tommy G
Director
$198.74K (2)
+$198.74K
144,290
0.0209%
$2.81M
+28.2%
Thomas John T
Director
$99.66K (2)
+$99.66K
829,975
0.1204%
$16.14M
+0.9%
Lias-Booker Ava
Director
$89.15K (1)
+$89.15K
45,305
0.0066%
$881.20K
+338.6%
SHELLEY-KESSLER PAMELA
Director
$49.99K (2)
+$49.99K
54,272
0.0079%
$1.06M
+73.9%
Scott Peter A
CFO
164,339
0.0238%
$3.20M
McHenry Troy E.
CLO and GC
138,258
0.0201%
$2.69M
+358.6%
HERZOG THOMAS M
CEO
96,067
0.0139%
$1.87M
+26.4%
HENRY DAVID
Director
84,910
0.0123%
$1.65M
+92.5%
Cartwright Brian G.
Director
83,490
0.0121%
$1.62M
+556.9%
SULLIVAN JOSEPH P
Director
80,590
0.0117%
$1.57M
+16.1%
Weiss Richard A.
Director
79,469
0.0115%
$1.55M
+60.6%
Hoffmann James P
Director
53,545
0.0078%
$1.04M
+14.3%
MCKEE MICHAEL D
Director
53,225
0.0077%
$1.04M
+0.8%
Bergschneider Jonathan M.
Senior Managing Director
44,366
0.0064%
$862.94K
−12.2%
Johnston Shawn G
EVP and CAO
42,260
0.0061%
$821.97K
Preston Glenn T
Executive Vice President
40,274
0.0058%
$783.34K
+14.0%
Connor James B.
Director
38,169
0.0055%
$742.40K
RHEIN PETER L
Director
37,795
0.0055%
$735.13K
+22.2%
Hutchens James Justin
President
37,038
0.0054%
$720.40K
−4.1%
Miller Jeffrey H
General Counsel
31,255
0.0045%
$607.92K
−29.5%
KENNARD LYDIA H
Director
27,826
0.0040%
$541.23K
Alonso Lisa A
EVP and Chief HR Officer
22,271
0.0032%
$433.18K
+28.6%
Patadia Ankit B.
EVP and Treasurer
8,953
0.0013%
$174.14K
−51.6%
Mabry Adam G
CIO
5,097
0.0007%
$99.14K
−71.9%
Moses Kelvin O
Chief Financial Officer
1,627
0.0002%
$31.65K
Insider
Date
Role
Action
Shares
Price
Amount
Bohn Scott R
12 May 2026
CDO and Head of Lab
Sell
10,989
$19.45
$213.74K
GARVEY CHRISTINE
22 Feb 2023
Director
Sell indirect
1,200
$25.45
$30.54K
GARVEY CHRISTINE
27 Dec 2022
Director
Sell indirect
1,000
$25.12
$25.12K
GARVEY CHRISTINE
16 Nov 2022
Director
Sell indirect
1,860
$24.77
$46.06K
GARVEY CHRISTINE
19 Nov 2021
Director
Sell indirect
300
$34.36
$10.31K
GARVEY CHRISTINE
9 Sep 2021
Director
Sell indirect
575
$36.20
$20.81K
GARVEY CHRISTINE
10 Jun 2021
Director
Sell indirect
889
$34.54
$30.71K
GARVEY CHRISTINE
6 May 2021
Director
Sell indirect
4,784
$33.39
$159.73K
GARVEY CHRISTINE
25 Feb 2021
Director
Sell indirect
340
$29.81
$10.14K
GARVEY CHRISTINE
23 Nov 2020
Director
Sell indirect
1,340
$30.81
$41.29K
GARVEY CHRISTINE
20 Feb 2020
Director
Sell indirect
550
$36.98
$20.34K
GARVEY CHRISTINE
9 May 2019
Director
Sell indirect
3,405
$29.80
$101.47K
Klaritch Thomas
13 Jun 2017
Senior Managing Director
Sell
2,651
$31.53
$83.60K
Anderson Scott A
16 Mar 2017
EVP and CAO
Sell
10,000
$29.94
$299.41K

What was left out

Form 4 filings counted 331
Amendments (4/A) skipped 1
Filings about a different issuer 1
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 2
Sales at will 14
Transactions with no price 0
Shares from compensation/vesting 5,327,471
Sales filed before the plan box existed 13
History held since 1 Sep 2016